Chau Vo, MD
Internal Medicine · Richmond, VANPI 1255728945
Payments from drug & device makers
Across 212 payments — averaging $113.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Abbott$7K
- Boston Scientific$5K
- Biotronik Inc.$2K
- Biosense Webster, Inc.$750
- Medical Device Business Services, Inc.$353
- plus $280 from 5 others
What the payments were for
- Grants$4,00017%
- Travel & lodging$11,49948%
- Food & beverage$7,39031%
- Education$1,1945%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 57 | $8,443 |
| Abbott | 71 | $6,792 |
| Boston Scientific | 32 | $5,158 |
| Biotronik Inc. | 3 | $2,306 |
| Biosense Webster, Inc. | 38 | $750 |
| Medical Device Business Services, Inc. | 1 | $353 |
| Cvrx, Inc. | 4 | $169 |
| Atricure, Inc. | 2 | $41 |
| Cardiva Medical, Inc. | 2 | $32 |
| Terumo Medical Corporation | 1 | $27 |
| Lantheus Medical Imaging, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$3,241
- GENERAL - THERAPIES$2,028
- Micra$1,503
- ENSITE PRECISION$1,268
- Carto 3$353
- WATCHMAN FLX$285
- WATCHMAN Access System$265
- ENSITE$209
- HeartMate 3 Left Ventricular Dev$183
- Farapulse$179
- Ensite Cardiac Mapping System$151
- AMPLATZER AMULET$133
- Barostim Neo System$103
How this compares
$24,083 in reported general payments places this provider in the 95th percentile of 2,724 internal medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 216 | $217,294 |
| MultaqDronedarone Hcl | 47 | $40,294 |
| XareltoRivaroxaban | 14 | $15,017 |
| Amiodarone Hcl | 55 | $1,595 |
| Metoprolol Succinate | 85 | $1,442 |
| Verapamil SrVerapamil Hcl | 13 | $621 |
| Flecainide Acetate | 18 | $542 |
| Carvedilol | 32 | $352 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 18 | $342 |
| Furosemide | 24 | $125 |
| Metoprolol Tartrate | 29 | $108 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Richmond
- Leroy VaughanRichmond$20.8M
- Andrew PoklepovicRichmond$4.6M
- Richard JacksonRichmond$2.5M
- Lawrence SchwartzRichmond$2.4M
- John HoekstraRichmond$344K
- Franklin ZieveRichmond$337K
- Wally SmithRichmond$333K
- Thokozeni LipatoRichmond$247K
- John BarrettRichmond$217K
- Alan DowRichmond$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.